March 1, 2000Warner Lambert Company Recalls
Procanbid Extended-Release Tablets
Morris Plains, NJ (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Warner Lambert Company is recalling certain
Procanbid Extended-Release Tablets, (Procainamide HCL), 500 mg, in 60 tablet
bottles, because of dissolution failure (2 hour time point).
According to the FDA, over 21,200
bottles were distributed nationwide. The recalled prescription, used as an
anti-arrhythmic bears the code of N0071-0562-20, Lot Number 40697D, EXP 7/00
This ongoing Class III recall
was initiated by Warner Lambert, by letter on December 23, 1999. This is the first
public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-211-0
Notice of this product warning was
sent via email to SafeMail
subscribers March 1, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.